CARsgen Therapeutics Holdings Limited
CARsgen Therapeutics Holdings Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and t…
Biotechnology
CN, Shanghai [HQ]
Cash Flow Statement
Configuration
In Million USD. Margins, Growth Rates In %
Cash Flow Statement
Sorry, seems like something went wrong
Info
No Data For 2171.HK's Cash Flow Statement
A data error can have several reasons, including but not limited to: Missing data (Most likely), Bugs, Javascript blocking